Evercore ISI Group Maintains Outperform on Edwards Lifesciences, Lowers Price Target to $92

Evercore ISI Group analyst Vijay Kumar maintains Edwards Lifesciences (NYSE:EW) with a Outperform and lowers the price target from $94 to $92.